% Depreciation & amortization 8,325 8,847 9,052 8.7% 2.3% 16,404 17,899 9.1% (Gain) loss on disposals of PPE 10 29 15 43% -48% 10 43 318% Management benefit expense (56) (35) (47) -16% 34% (104) (82) -21% Other
% 31,103 30,070 -3.3% Depreciation & amortization 6,262 7,332 7,738 24% 5.5% 14,839 21,986 48% (Gain) loss on disposals of PPE - (3) - NA -100% - 157 NA Management benefit expense (39) (48) (36) -6.6% -24
) loss on disposals of PPE 23 - 7 -69% NA 23 164 611% Management benefit expense (41) (36) (24) -41% -34% (150) (143) -5.0% Other financial cost (32) (13) (8) -75% -37% (181) (60) -67% EBITDA 15,058 17,589
% Depreciation & amortization 9,572 9,758 9,749 1.8% -0.1% 27,471 29,374 6.9% (Gain) loss on disposals of PPE -3 0 25 -875% n/a 40 25 -39% Management benefit expense -30 -40 -43 44% 8.5% -112 -123 10% Other
) loss on disposals of PPE (20) (3) 331 -1777% -10487% 2 371 15443% Management benefit expense (33) (30) (33) 5.7% 15% (177) (144) -18% Other financial cost 2 3 (0) -113% -110% (18) (0) -100% EBITDA 18,071
disposals of PPE 7 12 (20) -377% -270% 164 2 -99% Management benefit expense (24) (41) (32) 35% -22% (143) (177) 24% Other financial cost (8) (2) 2 -123% -230% (60) (18) -71% EBITDA 18,454 17,817 18,071 -2.1
12,862 13,009 13,377 4.0% 2.8% 25,869 26,386 2.0% (Gain) loss on disposals of PPE 16 8 -1 -106% -112% 16 7 -53% Management benefit expense -40 -45 -38 -5.5% -16% -80 -82 3.0% Other financial cost -4 -5 -8
% Depreciation & amortization 6,917 8,164 8,079 17% -1.0% (Gain) loss on disposals of PPE 160 7 - -100% -100% Management benefit expense (34) (24) (48) 38% 99% Other financial cost (23) (8) (6) -75% -32% EBITDA
% Depreciation & amortization 4,073 6,828 6,917 70% 1.3% (Gain) loss on disposals of PPE 0 23 160 NA 594% Management benefit expense (36) (41) (34) -3.9% -15% Other financial cost (59) (32) (23) -62% -31% EBITDA
disposals of PPE - 6 8 n/m 46% Management benefit expense -40 -45 -45 11% -0.3% Other financial cost -5 -4 -5 7.0% 28% EBITDA 22,777 22,234 22,580 -0.9% 1.6% EBITDA margin (%) 53.2% 48.3% 49.2% 6 1Q21 MD&A